Simon Williams, PhD

Simon Williams, PhD
Simon Williams, PhD CEO of Akeso Biomedical

Recent Posts

Akeso Biomedical Receives EU Authorization for CI-FER® as a Feed Additive in Piglets

CI-FER® reduces pathogen biofilms leading to improved zootechnical performance. BURLINGTON, MA – Akeso Biomedical, Inc., announced today that the company has obtained authorization in the European Union to market...

Akeso Biomedical Announces European Food Safety Authority Positive Scientific Opinion

Akeso Biomedical is pleased to announce that the European Food Safety Authority (EFSA) provided a positive scientific opinion for use of its CI-FER™ feed additive in weaners. The positive opinion was provided after the...

From The Corner Office: Akeso Biomedical Nears Commercial Sales Stage

As Akeso Biomedical embarks on its first in-the-field trials of its flagship product, CI-FERTM, it’s worthwhile looking back on the five-year journey that has taken us to this pivotal moment – years of product...


Zero Federal Capital Gains Taxes on High-Return Investments
White Paper
Portfolio Diversification in Times of Market Volatility
Protecting Early Investors in Capital-Intensive Life Science Companies
Inside Blackstone LaunchPad at UT Southwestern Medical Center with Brad Phelan
White Paper
University Technology Licensing: Assessing the Opportunities and Negotiating Licenses
VIC 2021 Mid-Year Update Executive Summary
Solaris Vaccines Formed to Develop and Commercialize a Rapid, Flexible Vaccine Manufacturing Platform
VIC Fellows Spotlight: Evan Goldberg, PhD
From The Corner Office
SFC Fluidics Nears FDA Submission